Clinical trial

Blood Pressure Regulation - Role of Potassium

NCT02380157

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-03-01

PhasePHASE4

Study timeline

Study start (unknown)2015-03-01Date precision: month

Registry last updated2017-01-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Blood Pressureunresolved

Hypertensionunresolved

Interventions

Kaleorid, 750mg (trade name), Potassium chloride (active substance)DRUG

PlaceboDRUG

Sponsors & collaborators

Glostrup University Hospital, Copenhagenlead sponsor

Danish Heart Foundationcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02380157 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.